Williams H, Langlois P F, Kelly J L
Wilford Hall Medical Center, Lackland AFB, TX 78236, USA.
Mil Med. 1995 Sep;160(9):449-52.
The purpose of this study was to determine whether intravenous nitroglycerin, when infused simultaneously through the same tubing with heparin, alters the anticoagulant effect of heparin as evidenced by partial thromboplastin time (PTT) values. A time series, cross-over design was used. The study included patients admitted to the Coronary Care Unit with a diagnosis of unstable angina. Patients were randomly assigned to one of two treatment groups: (1) heparin/nitroglycerin infused in the same site or (2) heparin/nitroglycerin infused in separate sites. After 18 hours, treatments were reversed. PTT results were measured seven times per subject. Ninety-eight subjects, 70 males and 28 females, participated. Mean age was 62.4 +/- 9 years. Using repeated measures analysis of variance, there was no change in the patients' PTTs (p = 0.47). Prior to this study, research was divided on whether nitroglycerin interferes with heparin's activity. This study indicates no significant difference in PTT in subjects receiving these infusions via separate or the same intravenous sites.
本研究的目的是确定静脉输注硝酸甘油时,若通过同一管道与肝素同时输注,是否会如部分凝血活酶时间(PTT)值所示改变肝素的抗凝作用。采用了时间序列交叉设计。该研究纳入了入住冠心病监护病房、诊断为不稳定型心绞痛的患者。患者被随机分配到两个治疗组之一:(1)在同一部位输注肝素/硝酸甘油,或(2)在不同部位输注肝素/硝酸甘油。18小时后,治疗方案互换。对每位受试者测量7次PTT结果。98名受试者参与研究,其中70名男性和28名女性。平均年龄为62.4±9岁。采用重复测量方差分析,患者的PTT没有变化(p = 0.47)。在本研究之前,关于硝酸甘油是否干扰肝素活性的研究存在分歧。本研究表明,通过不同或相同静脉部位接受这些输注的受试者的PTT无显著差异。